KBC Group
ENZN

KBC Group’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

KBC Group’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-170,928
Closed -$117K – 1338
2015
Q4 		$117K Sell
170,928
-28,850
-14% -$22.9K ﹤0.01% 1093
2015
Q3 		$194K Buy
199,778
+87,655
+78% +$108K ﹤0.01% 1014
2015
Q2 		$135K Buy
112,123
+69,324
+162% +$88.3K ﹤0.01% 1197
2015
Q1 		$45K Sell
42,799
-10,182
-19% -$10.5K ﹤0.01% 1283
2014
Q4 		$52K Buy
+52,981
New +$55.6K ﹤0.01% 1364

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

KBC Group's ENZN Position: Q1 2016 in Review

KBC Group sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2016, closing a stake of 170,928 shares — an estimated $117K sold.

KBC Group first reported a position in ENZN in Q4 2014 and held it in 5 quarters. The position peaked at $194K in Q3 2015. 40 funds tracked by Wall St. Rank hold ENZN as of Q1 2016.

  • KBC Group reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2016 after selling out during the quarter.
  • KBC Group sold 170,928 ENZON PHARMACEUTICALS INC shares in Q1 2016, an estimated $117K.
  • KBC Group first reported a position in ENZON PHARMACEUTICALS INC in Q4 2014 and held it in 5 quarters.
  • KBC Group's ENZON PHARMACEUTICALS INC position peaked at $194K in Q3 2015.
  • 40 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2016.

Based on KBC Group's 13F filing for Q1 2016, filed 11 May 2016.